News

Plasseraud IP at the 4th Pharma & Biotech Patent Litigation Europe Summit in Amsterdam
Patents

Plasseraud IP at the 4th Pharma & Biotech Patent Litigation Europe Summit in Amsterdam

Plasseraud IP Amsterdam had the privilege of attending the 4th Pharma & Biotech Patent Litigation Europe Summit on January 21st and 22nd 2025, and connecting with over 500 industry professionals, exchanging insights on the challenges and opportunities shaping patent litigation in the pharma and biotech sectors.

Over three action-packed days, the panels and roundtables covered critical topics, including UPC decisions, the evolving landscape of Pharma regulation in the EU, and the growing role of AI in life sciences. It was a fantastic opportunity to dive deep into these issues and network with patent practitioners from various jurisdictions.

We’re already looking forward to continuing these exciting discussions on the future of patent litigation and expanding our client base from our Amsterdam offices during 2025.

Share on: